Caleres (NYSE:CAL) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.40-2.50 for the period, compared to the Thomson Reuters consensus estimate of $2.45. The company issued revenue guidance of ~$2.8 billion, compared to the consensus revenue estimate of $2.84 billion.
CAL stock traded down $0.59 during mid-day trading on Friday, reaching $34.78. The company’s stock had a trading volume of 681,951 shares, compared to its average volume of 339,902. The company has a market cap of $1,475.47, a price-to-earnings ratio of 16.10, a PEG ratio of 1.26 and a beta of 0.94. The company has a current ratio of 1.97, a quick ratio of 0.64 and a debt-to-equity ratio of 0.27. Caleres has a fifty-two week low of $22.39 and a fifty-two week high of $36.00.
Caleres (NYSE:CAL) last announced its quarterly earnings results on Tuesday, March 13th. The textile maker reported $0.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.04. The business had revenue of $702.50 million during the quarter, compared to the consensus estimate of $695.61 million. Caleres had a net margin of 3.13% and a return on equity of 14.01%. The business’s revenue was up 9.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.33 EPS. equities analysts forecast that Caleres will post 2.48 earnings per share for the current year.
A number of equities analysts recently weighed in on CAL shares. Zacks Investment Research raised shares of Caleres from a hold rating to a buy rating and set a $33.00 price objective for the company in a research report on Friday, February 2nd. Susquehanna Bancshares reaffirmed a neutral rating and set a $33.00 price objective (up previously from $32.00) on shares of Caleres in a research report on Tuesday, January 23rd. Wedbush reaffirmed an outperform rating and set a $35.00 price objective on shares of Caleres in a research report on Wednesday, March 14th. UBS cut shares of Caleres from a positive rating to a neutral rating in a research report on Tuesday, January 23rd. Finally, ValuEngine raised shares of Caleres from a buy rating to a strong-buy rating in a research report on Monday. One research analyst has rated the stock with a sell rating, three have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Caleres presently has a consensus rating of Buy and a consensus target price of $35.20.
In other news, insider Daniel R. Freidman sold 2,000 shares of the firm’s stock in a transaction on Monday, March 19th. The shares were sold at an average price of $31.81, for a total value of $63,620.00. Following the sale, the insider now directly owns 91,733 shares in the company, valued at approximately $2,918,026.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Daniel R. Freidman sold 10,000 shares of the firm’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $28.45, for a total transaction of $284,500.00. Following the completion of the sale, the insider now owns 79,435 shares in the company, valued at $2,259,925.75. The disclosure for this sale can be found here. Company insiders own 6.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://baseballnewssource.com/2018/04/06/caleres-cal-updates-fy19-earnings-guidance/2037663.html.
Caleres Company Profile
Caleres, Inc, a footwear company, retails and wholesales footwear. The company operates through Famous Footwear and Brand Portfolio segments. It offers licensed, branded, and private-label casual, dress, and athletic footwear products to women, men, and children. The company operates retail shoe stores primarily under the Famous Footwear and Naturalizer names, which offer brand-name athletic, casual, and dress shoes, including company-owned and licensed brands, such as LifeStride, Dr.
Receive News & Ratings for Caleres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caleres and related companies with MarketBeat.com's FREE daily email newsletter.